Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

217 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Characteristics of Patients With Initial Clostridioides difficile Infection (CDI) That Are Associated With Increased Risk of Multiple CDI Recurrences.
Guh AY, Li R, Korhonen L, Winston LG, Parker E, Czaja CA, Johnston H, Basiliere E, Meek J, Olson D, Fridkin SK, Wilson LE, Perlmutter R, Holzbauer SM, D'Heilly P, Phipps EC, Flores KG, Dumyati GK, Pierce R, Ocampo VLS, Wilson CD, Watkins JJ, Gerding DN, McDonald LC. Guh AY, et al. Among authors: korhonen l. Open Forum Infect Dis. 2024 Mar 6;11(4):ofae127. doi: 10.1093/ofid/ofae127. eCollection 2024 Apr. Open Forum Infect Dis. 2024. PMID: 38577028 Free PMC article.
Trends in U.S. Burden of Clostridioides difficile Infection and Outcomes.
Guh AY, Mu Y, Winston LG, Johnston H, Olson D, Farley MM, Wilson LE, Holzbauer SM, Phipps EC, Dumyati GK, Beldavs ZG, Kainer MA, Karlsson M, Gerding DN, McDonald LC; Emerging Infections Program Clostridioides difficile Infection Working Group. Guh AY, et al. N Engl J Med. 2020 Apr 2;382(14):1320-1330. doi: 10.1056/NEJMoa1910215. N Engl J Med. 2020. PMID: 32242357 Free PMC article.
Comparison of the Risk of Recurrent Clostridioides Difficile Infections Among Patients in 2018 Versus 2013.
Guh AY, Yi SH, Baggs J, Winston L, Parker E, Johnston H, Basiliere E, Olson D, Fridkin SK, Mehta N, Wilson L, Perlmutter R, Holzbauer SM, D'Heilly P, Phipps EC, Flores KG, Dumyati GK, Hatwar T, Pierce R, Ocampo VLS, Wilson CD, Watkins JJ, Korhonen L, Paulick A, Adamczyk M, Gerding DN, Reddy SC. Guh AY, et al. Among authors: korhonen l. Open Forum Infect Dis. 2022 Aug 17;9(9):ofac422. doi: 10.1093/ofid/ofac422. eCollection 2022 Sep. Open Forum Infect Dis. 2022. PMID: 36072699 Free PMC article.
Potential underreporting of treated patients using a Clostridioides difficile testing algorithm that screens with a nucleic acid amplification test.
Guh AY, Fridkin S, Goodenough D, Winston LG, Johnston H, Basiliere E, Olson D, Wilson CD, Watkins JJ, Korhonen L, Gerding DN. Guh AY, et al. Among authors: korhonen l. Infect Control Hosp Epidemiol. 2024 May;45(5):590-598. doi: 10.1017/ice.2023.262. Epub 2024 Jan 25. Infect Control Hosp Epidemiol. 2024. PMID: 38268440 Free PMC article.
Risk factors for community-associated Clostridioides difficile infection in young children.
Weng MK, Adkins SH, Bamberg W, Farley MM, Espinosa CC, Wilson L, Perlmutter R, Holzbauer S, Whitten T, Phipps EC, Hancock EB, Dumyati G, Nelson DS, Beldavs ZG, Ocampo V, Davis CM, Rue B, Korhonen L, McDonald LC, Guh AY. Weng MK, et al. Among authors: korhonen l. Epidemiol Infect. 2019 Jan;147:e172. doi: 10.1017/S0950268819000372. Epidemiol Infect. 2019. PMID: 31063097 Free PMC article.
Reference Susceptibility Testing and Genomic Surveillance of Clostridioides difficile, United States, 2012-17.
Gargis AS, Karlsson M, Paulick AL, Anderson KF, Adamczyk M, Vlachos N, Kent AG, McAllister G, McKay SL, Halpin AL, Albrecht V, Campbell D, Korhonen LC, Elkins CA, Rasheed JK, Guh AY, McDonald LC, Lutgring JD; Emerging Infections Program C. difficile Infection Working Group. Gargis AS, et al. Among authors: korhonen lc. Clin Infect Dis. 2023 Mar 4;76(5):890-896. doi: 10.1093/cid/ciac817. Clin Infect Dis. 2023. PMID: 36208202 Free PMC article.
Characterization of Clostridioides difficile Isolates Available through the CDC & FDA Antibiotic Resistance Isolate Bank.
Paulick A, Adamczyk M, Anderson K, Vlachos N, Machado MJ, McAllister G, Korhonen L, Guh AY, Halpin AL, Rasheed JK, Karlsson M, Lutgring JD, Gargis AS; Emerging Infections Program Clostridioides difficile Pathogen Group. Paulick A, et al. Among authors: korhonen l. Microbiol Resour Announc. 2021 Jan 7;10(1):e01011-20. doi: 10.1128/MRA.01011-20. Microbiol Resour Announc. 2021. PMID: 33414286 Free PMC article.
Correction for Paulick et al., "Characterization of Clostridioides difficile Isolates Available through the CDC & FDA Antibiotic Resistance Isolate Bank".
Paulick A, Adamczyk M, Anderson K, Vlachos N, Machado MJ, McAllister G, Korhonen L, Guh AY, Halpin AL, Rasheed JK, Karlsson M, Lutgring JD, Gargis AS; Emerging Infections Program Clostridioides difficile Pathogen Group. Paulick A, et al. Among authors: korhonen l. Microbiol Resour Announc. 2022 May 19;11(5):e0030222. doi: 10.1128/mra.00302-22. Epub 2022 Apr 27. Microbiol Resour Announc. 2022. PMID: 35475673 Free PMC article. No abstract available.
Reply to Gonzales-Luna et al.
Gargis AS, Karlsson M, Kamile Rasheed J, Kent AG, McKay SL, Paulick AL, Anderson KF, Adamczyk M, Campbell D, Korhonen LC, McAllister G, Vlachos N, Halpin AL, Lutgring JD, Guh AY, Clifford McDonald L, Elkins CA. Gargis AS, et al. Among authors: korhonen lc. Clin Infect Dis. 2023 Jun 8;76(11):2039-2041. doi: 10.1093/cid/ciad133. Clin Infect Dis. 2023. PMID: 36883575 No abstract available.
217 results